Author Correction: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics

The Original Article was published on 08 September 2020

Correction to: Nature Communications, published online 08 September 2020.

The original version of this manuscript did not include a link to the RNA Extraction Procotol scripts that are publically available at Zenodo. The scripts can be found at the following URL:

In addition, the original version of this Article omitted a declaration from the Competing Interests statement, which should have included the following: “M. Priestman and M. Ciechonska are co-founders of Salient Labs. All other authors declare no competing interests.”

This has now been corrected in both the PDF and HTML versions of the Article.

Author information



Corresponding author

Correspondence to Paul S. Freemont.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Crone, M.A., Priestman, M., Ciechonska, M. et al. Author Correction: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics. Nat Commun 11, 4793 (2020).

Download citation


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing